Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 24 studies | 37% ± 20% | |
microglial cell | 13 studies | 50% ± 19% | |
astrocyte | 11 studies | 49% ± 18% | |
myeloid cell | 9 studies | 36% ± 19% | |
endothelial cell | 6 studies | 29% ± 6% | |
mononuclear phagocyte | 3 studies | 34% ± 5% | |
tissue-resident macrophage | 3 studies | 35% ± 17% | |
retinal pigment epithelial cell | 3 studies | 24% ± 5% | |
smooth muscle cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2105.48 | 244 / 245 | 99% | 23.27 | 496 / 502 |
thymus | 100% | 1877.00 | 652 / 653 | 96% | 20.87 | 582 / 605 |
lung | 100% | 2368.52 | 576 / 578 | 94% | 18.89 | 1081 / 1155 |
kidney | 100% | 1442.93 | 89 / 89 | 92% | 17.44 | 833 / 901 |
ovary | 100% | 2030.09 | 180 / 180 | 91% | 11.33 | 392 / 430 |
brain | 86% | 1364.79 | 2260 / 2642 | 100% | 35.52 | 702 / 705 |
bladder | 100% | 2184.48 | 21 / 21 | 83% | 11.20 | 418 / 504 |
breast | 100% | 2383.11 | 457 / 459 | 83% | 8.68 | 927 / 1118 |
stomach | 99% | 1856.19 | 357 / 359 | 82% | 10.06 | 235 / 286 |
adrenal gland | 100% | 8375.54 | 258 / 258 | 77% | 25.25 | 177 / 230 |
intestine | 99% | 1804.14 | 955 / 966 | 72% | 7.20 | 380 / 527 |
pancreas | 88% | 925.32 | 289 / 328 | 81% | 9.07 | 145 / 178 |
esophagus | 88% | 1686.11 | 1268 / 1445 | 80% | 11.36 | 146 / 183 |
uterus | 99% | 1987.22 | 169 / 170 | 67% | 8.41 | 308 / 459 |
liver | 86% | 968.41 | 195 / 226 | 76% | 12.18 | 307 / 406 |
skin | 54% | 639.16 | 984 / 1809 | 72% | 13.48 | 342 / 472 |
blood vessel | 100% | 3862.90 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2755.88 | 1201 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4852.81 | 240 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 26.00 | 75 / 80 |
tonsil | 0% | 0 | 0 / 0 | 73% | 11.36 | 33 / 45 |
heart | 70% | 617.26 | 603 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 4.96 | 15 / 29 |
peripheral blood | 33% | 344.61 | 304 / 929 | 0% | 0 | 0 / 0 |
muscle | 24% | 159.89 | 193 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0007283 | Biological process | spermatogenesis |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0001779 | Biological process | natural killer cell differentiation |
GO_0051250 | Biological process | negative regulation of lymphocyte activation |
GO_2000107 | Biological process | negative regulation of leukocyte apoptotic process |
GO_0007275 | Biological process | multicellular organism development |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0007267 | Biological process | cell-cell signaling |
GO_0030168 | Biological process | platelet activation |
GO_0032940 | Biological process | secretion by cell |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0060068 | Biological process | vagina development |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0006909 | Biological process | phagocytosis |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0007399 | Biological process | nervous system development |
GO_0016477 | Biological process | cell migration |
GO_0097350 | Biological process | neutrophil clearance |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0001750 | Cellular component | photoreceptor outer segment |
GO_0005737 | Cellular component | cytoplasm |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MERTK |
Protein name | MER proto-oncogene, tyrosine kinase receptor protein-tyrosine kinase (EC 2.7.10.1) Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) Uncharacterized protein MERTK |
Synonyms | MER |
Description | FUNCTION: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with GRB2 or PLCG2 and induces phosphorylation of MAPK1, MAPK2, FAK/PTK2 or RAC1. MERTK signaling plays a role in various processes such as macrophage clearance of apoptotic cells, platelet aggregation, cytoskeleton reorganization and engulfment . Functions in the retinal pigment epithelium (RPE) as a regulator of rod outer segments fragments phagocytosis. Also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3. . |
Accessions | E9PHX8 ENST00000409780.5 Q1RMG3 Q53QW0 ENST00000295408.9 H7C3L9 ENST00000449344.2 ENST00000439966.5 Q12866 Q53R53 E9PD22 |